X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (7) 7
gastroenterology & hepatology (5) 5
male (5) 5
aged (4) 4
female (4) 4
index medicus (4) 4
liver cancer (4) 4
middle aged (4) 4
adult (3) 3
animals (3) 3
cancer (3) 3
genotype (3) 3
health aspects (3) 3
hepatitis c virus (3) 3
hepatitis c, chronic - drug therapy (3) 3
immunohistochemistry (3) 3
mice (3) 3
treatment outcome (3) 3
young adult (3) 3
actins - physiology (2) 2
aged, 80 and over (2) 2
allele loss (2) 2
antiviral agents - adverse effects (2) 2
antiviral agents - therapeutic use (2) 2
carcinoma, hepatocellular - metabolism (2) 2
carcinoma, hepatocellular - pathology (2) 2
carcinoma, hepatocellular - prevention & control (2) 2
carcinoma, hepatocellular - secondary (2) 2
cell motility (2) 2
cell movement - physiology (2) 2
cirrhosis (2) 2
digestive system diseases (2) 2
drug-related side effects and adverse reactions - epidemiology (2) 2
drug-related side effects and adverse reactions - pathology (2) 2
enzyme inhibitors - pharmacology (2) 2
expression (2) 2
hepacivirus - classification (2) 2
hepacivirus - genetics (2) 2
hepacivirus - isolation & purification (2) 2
hepatitis (2) 2
hepatitis c (2) 2
hepatitis c, chronic - metabolism (2) 2
hepatitis c, chronic - virology (2) 2
hepatocellular carcinoma (2) 2
infectious diseases (2) 2
interferon therapy (2) 2
intracellular signaling peptides and proteins (2) 2
intrahepatic metastasis (2) 2
japan (2) 2
liver (2) 2
liver neoplasms - metabolism (2) 2
liver neoplasms - pathology (2) 2
liver neoplasms - prevention & control (2) 2
liver neoplasms - secondary (2) 2
lysophospholipids - pharmacology (2) 2
medical prognosis (2) 2
mice, scid (2) 2
neoplasm transplantation (2) 2
noncirrhotic patients (2) 2
product development (2) 2
rho-associated kinases (2) 2
ribavirin (2) 2
ribavirin - adverse effects (2) 2
risk factors (2) 2
sofosbuvir (2) 2
tumor cells, cultured (2) 2
uridine monophosphate - adverse effects (2) 2
uridine monophosphate - analogs & derivatives (2) 2
1 member b10 (1) 1
abridged index medicus (1) 1
actin (1) 1
actin cytoskeleton - metabolism (1) 1
actin stress fibers (1) 1
actins - drug effects (1) 1
activated protein-kinases (1) 1
adam protein (1) 1
adhesion (1) 1
administration, oral (1) 1
adp ribose transferases - pharmacology (1) 1
adp-ribosylation (1) 1
age factors (1) 1
akr1b10 (1) 1
aldehyde reductase - metabolism (1) 1
alpha-fetoprotein levels (1) 1
alpha-fetoproteins - metabolism (1) 1
amides - pharmacology (1) 1
amino acids (1) 1
analog (1) 1
analysis (1) 1
antiviral agents - administration & dosage (1) 1
article (1) 1
asian continental ancestry group (1) 1
benzimidazoles - administration & dosage (1) 1
benzimidazoles - adverse effects (1) 1
biliary (1) 1
blood physiological phenomena (1) 1
bone morphogenetic protein-1 (1) 1
botulinum toxins (1) 1
c virus-infection (1) 1
c-cbl (1) 1
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2015, Volume 15, Issue 6, pp. 645 - 653
Summary Background Compared with other countries, patients with chronic hepatitis C infection in Japan tend to be older, have more advanced liver disease, and... 
Infectious Disease | INFECTIOUS DISEASES | SIMEPREVIR | INFECTION | CHRONIC HCV | Uridine Monophosphate - administration & dosage | Humans | Middle Aged | Hepacivirus - genetics | Hepatitis C, Chronic - virology | Male | Drug-Related Side Effects and Adverse Reactions - pathology | Young Adult | Benzimidazoles - administration & dosage | Time Factors | Ribavirin - administration & dosage | Aged, 80 and over | Adult | Female | Fluorenes - administration & dosage | Fluorenes - adverse effects | Uridine Monophosphate - adverse effects | Benzimidazoles - adverse effects | Hepacivirus - isolation & purification | Administration, Oral | Japan | Genotype | Treatment Outcome | Hepatitis C, Chronic - drug therapy | Antiviral Agents - administration & dosage | Drug-Related Side Effects and Adverse Reactions - epidemiology | Asian Continental Ancestry Group | Ribavirin - adverse effects | Antiviral Agents - adverse effects | Uridine Monophosphate - analogs & derivatives | Aged | Hepacivirus - classification | Sofosbuvir | Care and treatment | Liver | Dosage and administration | Product development | Drug therapy, Combination | Hepatitis C virus | Hepatitis C | Health aspects | Ribavirin | Hepatitis | Genotype & phenotype | Liver cancer | Heart attacks | Liver diseases | Human immunodeficiency virus--HIV | Hepatology | Response rates | Interferon | Infections | Drug dosages | Patients
Journal Article
Journal of Viral Hepatitis, ISSN 1352-0504, 11/2014, Volume 21, Issue 11, pp. 762 - 768
Journal Article
Journal Article
Gastroenterology, ISSN 0016-5085, 2017, Volume 152, Issue 6, pp. 1383 - 1394
Background & Aims There is still a risk for hepatocellular carcinoma (HCC) development after eradication of hepatitis C virus (HCV) infection with antiviral... 
Gastroenterology and Hepatology | Metalloprotease | Genetics | Liver Cancer | Mutation | MAMMALIAN TOLLOID-LIKE | TGF-BETA | SUSTAINED RESPONSE | BONE MORPHOGENETIC PROTEIN-1 | NONCIRRHOTIC PATIENTS | RISK | PEGYLATED INTERFERON | DISEASE | SUSCEPTIBILITY LOCUS | GASTROENTEROLOGY & HEPATOLOGY | INTERFERON THERAPY | Hepatitis C, Chronic - metabolism | Age Factors | Carbon Tetrachloride | Humans | Middle Aged | Hepatic Stellate Cells - metabolism | Male | RNA, Messenger - metabolism | Tolloid-Like Metalloproteinases - genetics | Case-Control Studies | Carcinoma, Hepatocellular - genetics | Liver Cirrhosis - metabolism | Female | Liver Cirrhosis - genetics | alpha-Fetoproteins - metabolism | Fatty Liver - genetics | Liver Neoplasms - virology | Genome-Wide Association Study | Liver Neoplasms - genetics | Antiviral Agents - therapeutic use | Introns | Risk Factors | Rats | Carcinoma, Hepatocellular - virology | Hepatitis C, Chronic - drug therapy | Diabetes Complications - complications | Animals | Choline - administration & dosage | Liver Neoplasms - metabolism | Sex Factors | Aged | Mice | Polymorphism, Single Nucleotide | Sustained Virologic Response | Hepatitis C, Chronic - genetics | Carcinoma, Hepatocellular - metabolism | Fatty Liver - etiology | Serum Albumin - metabolism | Virus diseases | Control | Genomics | Genetic research | Genetic aspects | Hepatoma | Hepatitis C virus | Health aspects | Trade and professional associations | Cancer | Analysis | Index Medicus | Abridged Index Medicus
Journal Article
Hepatology, ISSN 0270-9139, 10/1999, Volume 30, Issue 4, pp. 1027 - 1036
Journal Article
世界肝病学杂志:英文版(电子版), ISSN 1948-5182, 2013, Volume 5, Issue 3, pp. 90 - 96
AIM: To elucidate the effect of saliva stimulation by nizatidine on oral symptoms of primary biliary cirrhosis (PBC) by administering it to PBC cases. METHODS:... 
analog | mouth | Nizatidine | syndrome | biliary | Primary | Sicca | scale | Dry | cirrhosis | Visual | Visual analog scale | Primary biliary cirrhosis | Dry mouth | Sicca syndrome | Original
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.